High Sensitivity Troponin Test Demonstrates Better Diagnostic Accuracy in Acute Coronary Syndrome Cases: Systematic Review

Published On 2024-09-26 03:15 GMT   |   Update On 2024-09-26 03:15 GMT

High-sensitivity troponin shows promise in diagnosing acute coronary syndrome in primary care settings. The findings were published in the Annals of Family Medicine.

Chest pain can be caused by both serious conditions and more benign issues. The present study assessed the effectiveness of various risk stratification tools, including clinical decision rules and troponin tests, in helping general practitioners rule out acute coronary syndrome in patients with chest pain.
Researchers conducted a systematic review of studies involving adult patients presenting with chest pain in primary care settings. The review included studies that examined the diagnostic accuracy of different clinical decision rules and troponin point-of-care tests, both conventional and high-sensitivity, in identifying acute coronary syndrome, which includes heart attacks. The study compared these tools to the unaided clinical judgment of general practitioners.
Advertisement
14 studies were included in the final review.
• Some of the clinical decision rules without troponin improved safety. However, none consistently outperformed unaided general practitioner judgment in ruling out acute coronary syndrome.
• Conventional troponin as a standalone test did not meet the desired diagnostic accuracy, making the tests less reliable in primary care settings.
• High-sensitivity troponin tests demonstrated the highest diagnostic accuracy. However, this finding requires further prospective validation in primary care before it can be recommended for widespread use.
Although high-sensitivity troponin tests hold promise, they are not yet ready to replace clinical judgment or be used independently in primary care settings without further validation.
Reference: van den Bulk, S., Manten, A., Bonten, T. N., & Harskamp, R. E. (2024). Chest pain in primary care: A systematic review of risk stratification tools to rule out acute coronary syndrome. The Annals of Family Medicine, 22(5), 426-436. https://doi.org/10.1370/afm.3141
Full View
Tags:    
Article Source : Annals of Family Medicine

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News